Objectives: To give an overview on state of the art and future projects and challanges of the most commonly used toxins in Europe and the US
Introduction: More an more toxins are comming to the market. This might be specifically for novices confusing. Together with the industry we would give an overview on the present toxins on the Europen and US market.
Materials / method: Based on the answers of the companies on a pre-meeting questionnaire a presentation was developed that will be presented by the representatives of the companies and moderated by the two chairs.
Results: The following questions will be discussed: (1) Characteristics of the toxins including differences to the other toxins (2) the evidence based on clinical and preclinical trials (3) new aspects (4) toxin fatigue (5) the longterm efficacy
利益冲突声明
您有否接受任何资金来支持研究这个主题?
否
您是否接受过关于这项研究的任何酬金或其他报酬?
否
你是否和任何与您的研究所涉及的药物,材料或工具有密切联系的实体存在财务关系?
否
你是否拥有或者您已经为您此研究中的工具,药物或材料申请任何专利?
否
这项工作没有任何直接或间接的资金支持。由作者自己承担责任。